Introduction:Basic information about CAS 69884-00-0|Pseudoginsenoside F11, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Pseudoginsenoside F11 |
|---|
| CAS Number | 69884-00-0 | Molecular Weight | 801.013 |
|---|
| Density | 1.3±0.1 g/cm3 | Boiling Point | 885.3±65.0 °C at 760 mmHg |
|---|
| Molecular Formula | C42H72O14 | Melting Point | / |
|---|
| MSDS | ChineseUSA | Flash Point | 489.2±34.3 °C |
|---|
| Symbol | GHS07 | Signal Word | Warning |
|---|
Names
| Name | (3b,6a,12b,24R)-20,24-Epoxy-3,12,25-trihydroxydammaran-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside |
|---|
| Synonym | More Synonyms |
|---|
Pseudoginsenoside F11 BiologicalActivity
| Description | Pseudoginsenoside-F11 (PF11), a component of Panax quinquefolium (American ginseng), has been demonstrated to antagonize the learning and memory deficits induced by scopolamine, morphine and methamphetamine in mice. IC50 value: Inhibition of diprenorphine binding with an IC50 of 6.1 μM Target:In vitro: Biochemical experiments revealed that PF11 could inhibit diprenorphine (DIP) binding with an IC50 of 6.1 μM and reduced the binding potency of morphine in Chinese hamster ovary (CHO)-μ cells [2].In vivo: One in vivo model of cisplatin-induced acute renal failure was performed. The results showed that pretreatment with Pseudoginsenoside F11 reduced cisplatin-elevated blood urea nitrogen and creatinine levels, as well as ameliorated the histophathological damage [1]. We tested the effects of Pseudoginsenoside F11 on morphine-induced development of behavioral sensitization and alterations in glutamate levels in the medial prefrontal cortex (mPFC) in freely moving mice by using in vivo microdialysis. As the results shown, Pseudoginsenoside F11 antagonized the development of behavioral sensitization and decrease of glutamate in the mPFC induced by morphine [3]. |
|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>OthersNatural Products >>Terpenoids and Glycosides |
|---|
| References | [1]. Wang H, et al. The pseudoginsenoside F11 ameliorates cisplatin-induced nephrotoxicity without compromising its anti-tumor activity in vivo. Scientific Reports [2014, 4:4986] [2]. Li Zhu, et al. Pseudoginsenoside-F11 attenuates morphine-induced signalling in Chinese hamster ovary-μ cells. Neuroreport, 25 May 2001 - Volume 12 - Issue 7 - pp 1453-1456 [3]. Yue Hao, et al. Pseudoginsenoside-F11 decreases morphine-induced behavioral sensitization and extracellular glutamate levels in the medial prefrontal cortex in mice. Pharmacology Biochemistry and Behavior Volume 86, Issue 4, April 2007, Pages 660–666 |
|---|
Chemical & Physical Properties
| Density | 1.3±0.1 g/cm3 |
|---|
| Boiling Point | 885.3±65.0 °C at 760 mmHg |
|---|
| Molecular Formula | C42H72O14 |
|---|
| Molecular Weight | 801.013 |
|---|
| Flash Point | 489.2±34.3 °C |
|---|
| Exact Mass | 800.492188 |
|---|
| PSA | 228.22000 |
|---|
| LogP | 5.27 |
|---|
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
|---|
| Index of Refraction | 1.599 |
|---|
| InChIKey | JBGYSAVRIDZNKA-NOYKOGHLSA-N |
|---|
| SMILES | CC1OC(OC2C(OC3CC4(C)C(CC(O)C5C(C6(C)CCC(C(C)(C)O)O6)CCC54C)C4(C)CCC(O)C(C)(C)C34)OC(CO)C(O)C2O)C(O)C(O)C1O |
|---|
| Storage condition | 2-8°C |
|---|
Safety Information
| Symbol | GHS07 |
|---|
| Signal Word | Warning |
|---|
| Hazard Statements | H302 |
|---|
| Hazard Codes | Xn |
|---|
| Risk Phrases | 22 |
|---|
| Safety Phrases | 24/25 |
|---|
| RIDADR | NONH for all modes of transport |
|---|
| HS Code | 29389090 |
|---|
Synonyms
| (3β,6α,12β,24R)-3,12,25-Trihydroxy-20,24-epoxydammaran-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-mannopyranoside |
| pseudo-ginsenoside-Fll |
| GINSENOSIDE A1 |
| β-D-Mannopyranoside, (3β,6α,12β,24R)-20,24-epoxy-3,12,25-trihydroxydammaran-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)- |
| (3b,6a,12b,24R)-20,24-Epoxy-3,12,25 |
| MFCD00803938 |
| PSEUDOGINSENOSIDE |
| Pseuginsenoside F11 |
| (24R)-Pseudoginsenoside F11 |
| 24(S)-pseudo-ginsenoside-F11 |
| Pseudoginsenoside FII |
| Pseudoginsenoside-F11 |
| Pseuginsensoside F11 |
| Pseudoginsenoside F11 |